Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$448K Buy
1,600
+399
+33% +$105K ﹤0.01% 732
2026
Q1
$320K Buy
+1,201
New +$325K ﹤0.01% 755
2024
Q1
Sell
-4,433
Closed -$1.01M 600
2023
Q4
$1.01M Buy
+4,433
New +$931K 0.04% 222

Other funds holding LH

Marex Group's LH Position: Q2 2026 in Review

Marex Group increased its Labcorp (LH) stake by 33% in Q2 2026, buying an estimated $105K and bringing the position to 1,600 shares worth $448K. The position accounts for ﹤0.01% of the portfolio, ranked #732.

Marex Group first reported a position in LH in Q4 2023 and has held it in 3 quarters since. The position peaked at $1.01M in Q4 2023. 1,053 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Marex Group held 1,600 shares of Labcorp worth $448K as of Q2 2026.
  • Marex Group bought 399 Labcorp shares in Q2 2026, an estimated $105K.
  • Labcorp made up ﹤0.01% of Marex Group's portfolio in Q2 2026, its #732 holding.
  • Marex Group first reported a position in Labcorp in Q4 2023 and has held it in 3 quarters since.
  • Marex Group's Labcorp position peaked at $1.01M in Q4 2023.
  • 1,053 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.